7
Participants
Start Date
January 22, 2018
Primary Completion Date
November 20, 2018
Study Completion Date
January 1, 2019
saproterin dihydrochloride
The drug will be given as described in the arm/group descriptions.
Diet treatment
Patients will maintain a stable, Phe restricted diet (including formula) that is consistent with their diet at the time of enrollment. This will be monitored by food diaries kept for 3 days of each week.
University Hospitals Cleveland Medical Center, Cleveland
Collaborators (1)
BioMarin Pharmaceutical
INDUSTRY
University Hospitals Cleveland Medical Center
OTHER